Merck is ending a Phase 3 trial of Winrevair early so all PAH patients in HYPERION can start active treatment with the drug ...

Columnist Anna Jeter appreciates how much her maternal grandparents meant to her family as she dealt with pulmonary hypertension.

Men with PAH had a larger right heart size and worse survival than women, independent of body size and functional status, a ...

As someone living with PH and coexisting conditions, columnist Jen Cueva has had to learn how to deal with frustrating health setbacks.

LungFit PH, a device developed by Beyond Air for administering nitric oxide (NO) therapy, has received marketing approval from the Australian Therapeutic Goods Administration (TGA), which will allow ...